Compare NKTX & EPSN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | NKTX | EPSN |
|---|---|---|
| Founded | 2015 | 2005 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Oil & Gas Production |
| Sector | Health Care | Energy |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 132.8M | 132.1M |
| IPO Year | 2020 | 2018 |
| Metric | NKTX | EPSN |
|---|---|---|
| Price | $2.32 | $5.73 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 5 | 0 |
| Target Price | ★ $13.25 | N/A |
| AVG Volume (30 Days) | ★ 669.7K | 210.7K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | ★ 4.43% |
| EPS Growth | ★ 33.33 | N/A |
| EPS | N/A | ★ 0.30 |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $41.35 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $18.80 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.31 | $4.20 |
| 52 Week High | $2.81 | $8.50 |
| Indicator | NKTX | EPSN |
|---|---|---|
| Relative Strength Index (RSI) | 46.74 | 67.93 |
| Support Level | $1.95 | $5.33 |
| Resistance Level | $2.47 | $6.06 |
| Average True Range (ATR) | 0.19 | 0.19 |
| MACD | -0.03 | 0.04 |
| Stochastic Oscillator | 4.76 | 77.13 |
Nkarta Inc is a clinical-stage biopharmaceutical company pioneering the development of allogeneic, off-the-shelf engineered natural killer (NK) cell therapies. The Company is engaged in leveraging the natural potent power of NK cells to identify and kill abnormal cells and recruit adaptive immune effectors to generate responses that are specific and durable. The company is combining its NK expansion platform technology with proprietary cell engineering technologies to generate an abundant supply of NK cells, engineer enhanced NK cell recognition of therapeutic targets, and improve persistence for sustained activity in the body for the treatment of cancer.
Epsilon Energy Ltd is engaged in the acquisition, development, gathering, and production of natural gas and oil reserves. The operating segments of the company include Upstream segment activities including acquisition, development, and production of natural gas reserves on properties within the United States. The Gas Gathering segment partners with two other companies to operate a natural gas gathering system, and the corporate segment activities include corporate listing and governance functions of the corporation. The company generates revenue from the sale of crude oil and natural gas.